Philip Simonson

Philip Simonson is a seasoned professional in regulatory sciences, currently serving as Senior Vice President of CMC Regulatory Sciences at ProPharma since October 2023. His extensive career includes key positions such as Vice President of Global Regulatory Affairs - CMC at ICON plc and Executive Director of Global Regulatory Affairs - CMC at PRA Health Sciences. Prior roles include leadership in regulatory affairs at Perrigo Company plc, Cephalon, Pfizer, and Parke-Davis, showcasing a deep expertise in CMC regulatory pathways. Philip Simonson holds a Ph.D. in Analytical Chemistry from the University of Iowa and an MBA from the University of Michigan - Stephen M. Ross School of Business, complemented by a B.S. in Chemistry from the University of Wisconsin-Superior.